The U.S. Food and Drug Administration today (August 30) approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.

The U.S. Food and Drug Administration approved Evithrom (human thrombin), a blood-clotting protein used to help control bleeding during surgery.

The U.S. Food and Drug Administration today (August 28) announced approval of a second test for the detection of West Nile virus (WNV) in blood and organs.

The U.S. Food and Drug Administration is alerting consumers that Mars Petcare US, Inc. has recalled two dry dog food products because of the potential contamination with Salmonella Schwarzengrund.

Additional Growing Area Linked to Illness Outbreaks

Highlights Include New UVA Rating System, Sun Warning Information

The U.S. Food and Drug Administration today (August 22) approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17. This is the first FDA approval of an atypical antipsychotic drug to treat either disorder in these age groups.

May Increase Chance of Serious Side Effects in Infants

Health Canada is advising Canadians of a recall in the United States of one lot of Metaboslim Apple Cider Vinegar, which is marketed as a dietary supplement, because it has been found to contain sibutramine, a prescription medication that should only be taken under medical supervision.

New Genetic Information May Help Providers Improve Initial Dosing Estimates of the Anticoagulant for Individual Patients

The U.S. Food and Drug Administration today (August 14) announced manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning on the risk of heart failure, a condition that occurs when the heart does not adequately pump blood.

FDA Grants Tentative Approval for 50th and 51st Anti-Retroviral Drugs Under President's AIDS Relief Plan